Modernizing FDA's Supplement Industry Regulation Mapped Out In Five-Point Plan
Executive Summary
Commissioner Scott Gottlieb announces FDA's plan for policy changes to implement "one of the most significant modernizations of dietary supplement regulation and oversight in more than 25 years." Plan includes steps to ensure its regulatory framework is flexible enough to adequately evaluate product safety while also promoting innovation, particularly finalizing NDI notifications guidance and fostering submissions of the notifications.
You may also be interested in...
Final Conviction In US FDA's Spiked-Supplement Investigation Of Blackstone Labs
James Boccuzzi was the last person sentenced in connection with FDA's investigation of sports supplement firm Blackstone Labs for selling steroid-containing supplements after it ignored agency's warning to stop.
Regulation Of US Supplement Industry Needs ‘Really Hard Look’ – FDA's Woodcock
Acting commissioner's comment on supplement industry regulation was her most definitive statement about the agency’s work in consumer health sector at CHPA's regulatory conference. Pandemic, she says, heightened consumer interest in self-care along with demand for OTC drugs and supplements.
US Rule For Mandatory Supplement Registration Would Likely Give FDA Authority For Fines
“We would certainly want to have some enforcement and be able to utilize that enforcement,” says ODSP acting director Cara Welch. Stakeholders opposed to the change should “get comfortable with the idea of opening up DSHEA and should most certainly be part of the discussion.”